CN102869773A - 无色肽酶用于室温下裂解的用途 - Google Patents
无色肽酶用于室温下裂解的用途 Download PDFInfo
- Publication number
- CN102869773A CN102869773A CN2011800203890A CN201180020389A CN102869773A CN 102869773 A CN102869773 A CN 102869773A CN 2011800203890 A CN2011800203890 A CN 2011800203890A CN 201180020389 A CN201180020389 A CN 201180020389A CN 102869773 A CN102869773 A CN 102869773A
- Authority
- CN
- China
- Prior art keywords
- biological sample
- nucleic acid
- sample
- cracking
- achromopeptidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010053229 Lysyl endopeptidase Proteins 0.000 title claims abstract description 50
- 230000009089 cytolysis Effects 0.000 title description 7
- 239000000523 sample Substances 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 60
- 241000894006 Bacteria Species 0.000 claims abstract description 54
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 51
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 51
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 51
- 239000012472 biological sample Substances 0.000 claims abstract description 37
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 13
- 230000001413 cellular effect Effects 0.000 claims abstract description 13
- 241000193985 Streptococcus agalactiae Species 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 9
- 230000002934 lysing effect Effects 0.000 claims abstract 2
- 238000005336 cracking Methods 0.000 claims description 68
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 16
- 239000002953 phosphate buffered saline Substances 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 12
- 239000000470 constituent Substances 0.000 claims description 10
- 238000013016 damping Methods 0.000 claims description 10
- 229940030998 streptococcus agalactiae Drugs 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 241001153886 Ami Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 230000035899 viability Effects 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 239000002689 soil Substances 0.000 claims description 5
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 claims description 4
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims description 4
- 239000006166 lysate Substances 0.000 claims description 4
- 229960003085 meticillin Drugs 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 206010036790 Productive cough Diseases 0.000 claims description 2
- 210000003097 mucus Anatomy 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 210000003802 sputum Anatomy 0.000 claims description 2
- 208000024794 sputum Diseases 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims 9
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 230000002255 enzymatic effect Effects 0.000 abstract description 5
- 238000003752 polymerase chain reaction Methods 0.000 abstract description 3
- 241000124008 Mammalia Species 0.000 abstract description 2
- 241000192125 Firmicutes Species 0.000 abstract 2
- 239000000284 extract Substances 0.000 description 28
- 238000000605 extraction Methods 0.000 description 27
- 239000000243 solution Substances 0.000 description 19
- 238000012546 transfer Methods 0.000 description 19
- 229920000742 Cotton Polymers 0.000 description 13
- 238000005070 sampling Methods 0.000 description 13
- 241000271897 Viperidae Species 0.000 description 11
- 230000004087 circulation Effects 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000012447 hatching Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000008953 bacterial degradation Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002101 lytic effect Effects 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 3
- 108010013639 Peptidoglycan Proteins 0.000 description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000012387 aerosolization Methods 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960002901 sodium glycerophosphate Drugs 0.000 description 1
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 description 1
- 229940046307 sodium thioglycolate Drugs 0.000 description 1
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31431810P | 2010-03-16 | 2010-03-16 | |
| US61/314,318 | 2010-03-16 | ||
| PCT/US2011/028494 WO2011115975A2 (en) | 2010-03-16 | 2011-03-15 | Use of achromopeptidase for lysis at room temperature |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102869773A true CN102869773A (zh) | 2013-01-09 |
Family
ID=44649786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011800203890A Pending CN102869773A (zh) | 2010-03-16 | 2011-03-15 | 无色肽酶用于室温下裂解的用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110275090A1 (enExample) |
| EP (1) | EP2547767A4 (enExample) |
| JP (1) | JP2013521804A (enExample) |
| CN (1) | CN102869773A (enExample) |
| AU (1) | AU2011227452B2 (enExample) |
| BR (1) | BR112012023875A2 (enExample) |
| CA (1) | CA2793144A1 (enExample) |
| WO (1) | WO2011115975A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10654021B2 (en) | 2016-11-14 | 2020-05-19 | Airbus Operations Gmbh | Autoclave and method for welding thermoplastic composite parts |
| CN118834934A (zh) * | 2024-08-19 | 2024-10-25 | 希莱乐检(郑州)生物科技有限公司 | 用于结核分枝杆菌核酸释放的裂解液及其应用 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8597884B2 (en) | 2011-03-09 | 2013-12-03 | Becton, Dickinson And Company | Process controls for molecular assay |
| US9528987B2 (en) | 2011-06-23 | 2016-12-27 | University Of Washington | Reagent patterning in capillarity-based analyzers and associated systems and methods |
| WO2013117968A1 (en) | 2012-02-10 | 2013-08-15 | Reametrix Inc. | Methods for lysing bacteria from sample and isolating cellular components therefrom, and kits therefor |
| EP2948249A1 (en) | 2013-01-22 | 2015-12-02 | University of Washington through its Center for Commercialization | Sequential delivery of fluid volumes and associated devices, systems and methods |
| CN111278844B (zh) * | 2017-09-13 | 2023-12-19 | 贝克顿·迪金森公司 | 用于使用氧化铁颗粒提取核酸的方法和组合物 |
| WO2021217173A1 (en) * | 2020-04-21 | 2021-10-28 | Siemens Healthcare Diagnostics Inc. | Clinical specimen collection swabs for molecular diagnostic applications and methods of production and use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185242A (en) * | 1991-06-24 | 1993-02-09 | Becton Dickinson And Company | Method for lysing mycobacteria using achromopeptidase |
| US5508164A (en) * | 1990-10-29 | 1996-04-16 | Dekalb Genetics Corporation | Isolation of biological materials using magnetic particles |
| US20040002594A1 (en) * | 2002-06-27 | 2004-01-01 | John Krupey | Removal of extraneous substances from biological fluids containing nucleic acids and the recovery of nucleic acids |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8414273D0 (en) * | 1984-06-05 | 1984-07-11 | Oxoid Ltd | Identifying streptococcal grouping |
| JP2589729B2 (ja) * | 1988-01-30 | 1997-03-12 | 極東製薬工業株式会社 | 染色体ｄｎａを用いた細菌の同定方法および該同定用キット |
| US5973138A (en) * | 1998-10-30 | 1999-10-26 | Becton Dickinson And Company | Method for purification and manipulation of nucleic acids using paramagnetic particles |
| JP3172917B2 (ja) * | 1999-07-23 | 2001-06-04 | 北海道 | 細菌検出方法 |
| US7595176B2 (en) * | 2003-05-30 | 2009-09-29 | Georgia Tech Research Corporation | Methods and reagents for quantitative analysis of Dehalococcoides species |
| WO2005064016A1 (ja) * | 2003-12-26 | 2005-07-14 | Prima Meat Packers, Ltd. | 微生物の多重検出方法 |
| US20060057613A1 (en) * | 2004-07-26 | 2006-03-16 | Nanosphere, Inc. | Method for distinguishing methicillin resistant S. aureus from methicillin sensitive S. aureus in a mixed culture |
| AU2006271104B2 (en) * | 2005-07-21 | 2011-01-27 | Morinaga Milk Industry Co., Ltd. | Method for detection of microorganism and kit for detection of microorganism |
| JP2010510524A (ja) * | 2006-11-22 | 2010-04-02 | スリーエム イノベイティブ プロパティズ カンパニー | 試料を調製及び分析するシステム並びに方法 |
| JP2008148570A (ja) * | 2006-12-14 | 2008-07-03 | Hitachi Ltd | 微生物検出システム |
| US20090215050A1 (en) * | 2008-02-22 | 2009-08-27 | Robert Delmar Jenison | Systems and methods for point-of-care amplification and detection of polynucleotides |
| US20090274577A1 (en) * | 2008-05-05 | 2009-11-05 | B-K Medical Aps | Sterilization by treatment with reductant and oxidant |
-
2011
- 2011-03-15 WO PCT/US2011/028494 patent/WO2011115975A2/en not_active Ceased
- 2011-03-15 JP JP2013500151A patent/JP2013521804A/ja active Pending
- 2011-03-15 CN CN2011800203890A patent/CN102869773A/zh active Pending
- 2011-03-15 US US13/048,539 patent/US20110275090A1/en not_active Abandoned
- 2011-03-15 EP EP11756845.1A patent/EP2547767A4/en not_active Withdrawn
- 2011-03-15 CA CA2793144A patent/CA2793144A1/en not_active Abandoned
- 2011-03-15 BR BR112012023875A patent/BR112012023875A2/pt not_active Application Discontinuation
- 2011-03-15 AU AU2011227452A patent/AU2011227452B2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508164A (en) * | 1990-10-29 | 1996-04-16 | Dekalb Genetics Corporation | Isolation of biological materials using magnetic particles |
| US5185242A (en) * | 1991-06-24 | 1993-02-09 | Becton Dickinson And Company | Method for lysing mycobacteria using achromopeptidase |
| US20040002594A1 (en) * | 2002-06-27 | 2004-01-01 | John Krupey | Removal of extraneous substances from biological fluids containing nucleic acids and the recovery of nucleic acids |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10654021B2 (en) | 2016-11-14 | 2020-05-19 | Airbus Operations Gmbh | Autoclave and method for welding thermoplastic composite parts |
| CN118834934A (zh) * | 2024-08-19 | 2024-10-25 | 希莱乐检(郑州)生物科技有限公司 | 用于结核分枝杆菌核酸释放的裂解液及其应用 |
| CN118834934B (zh) * | 2024-08-19 | 2025-05-16 | 希莱乐检(郑州)生物科技有限公司 | 用于结核分枝杆菌核酸释放的裂解液及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2793144A1 (en) | 2011-09-22 |
| JP2013521804A (ja) | 2013-06-13 |
| US20110275090A1 (en) | 2011-11-10 |
| AU2011227452A1 (en) | 2012-10-04 |
| WO2011115975A3 (en) | 2012-01-19 |
| WO2011115975A2 (en) | 2011-09-22 |
| EP2547767A4 (en) | 2013-12-25 |
| AU2011227452B2 (en) | 2015-04-09 |
| BR112012023875A2 (pt) | 2015-09-22 |
| EP2547767A2 (en) | 2013-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102869773A (zh) | 无色肽酶用于室温下裂解的用途 | |
| JP6670765B2 (ja) | 生物試料中の核酸を安定化する組成物および方法 | |
| US12378545B2 (en) | Method for nucleic acid depletion | |
| JP2016523536A (ja) | 標的抗生物質の感受性試験方法 | |
| US10774322B2 (en) | Combined lysis protocol for comprehensive cell lysis | |
| CN102363815B (zh) | 运用交叉引物核酸恒温扩增技术检测沙门菌的试剂及其扩增方法和检测方法 | |
| US9670478B2 (en) | Method for modifying nucleic acids | |
| EP2888364B1 (en) | Method for efficient isolation of microbial dna from blood | |
| AU2006209416A1 (en) | Method of quantitatively analysing microorganism targeting rRNA | |
| CN114981425A (zh) | 用于消化样品中核酸的方法 | |
| De Felice et al. | Latest trends in biosensors powered by nucleic acid isothermal amplification for the diagnosis of joint infections: From sampling to identification towards the point-of-care | |
| CN103014174B (zh) | 猪支原体肺炎pcr诊断试剂盒 | |
| RU2795460C1 (ru) | Метод определения ДНКазной активности в режиме реального времени | |
| CN102766680B (zh) | 金黄色葡萄球菌、溶血性链球菌检测试剂盒及检测方法 | |
| Jacobsen | Investigating the Effects of Time and Temperature Degradation on Oral Bacteria Using qPCR for the Forensic Identification of Saliva | |
| WO2007116450A1 (ja) | 核酸抽出方法及び核酸抽出キット | |
| Sasidharan et al. | An optimized protocol for isolating Rhinosporidium seeberi sporangia from rhinosporidiosis tissue and extracting genomic DNA for next-generation sequencing | |
| Truong | Analysis of pre-sequencing methodologies for determining species and relative abundance in skin microbiome communities | |
| Heinemann et al. | Comparison of DNA extraction protocols to detect Mycobacterium bovis in bovine tissue by PCR Comparação de protocolos de extração de DNA para detectar Mycobacterium bovis em tecido bovino por PCR | |
| Riskumäki | Optimizing methods for analyzing the skin microbiota | |
| WO2022085530A1 (ja) | 外来性核酸を検出する方法に供する試料の調製のための前処理方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130109 |